UKGrowth Network

UK company record

Mission Therapeutics

Deubiquitylating enzyme (DUB) inhibitor drug discovery

CandidateCore UK
Open interactive recordCompanies House profile

Snapshot

UK location
Cambridge · East of England
Sector
Biotech & techbio
Latest recorded round
Series D
Latest recorded amount
£25.2M
Date
2024-03-01

Legal-identity layer

Candidate identity.

Selected legal name
MISSION THERAPEUTICS LIMITED
Company number
07630933
Companies House status
active
Incorporated
2011-05-11

Investors

Current directors and active controllers

  • HARMEIER, Anja, DrCurrent director
  • HEPPLE, Jonathan Paul, DrCurrent director
  • IP2IPO SERVICES LIMITEDCurrent director
  • LUNDEMOSE, Anker, DrCurrent director
  • MUFTI, Iqbal RasoolCurrent director
  • PEAKMAN, Marie-Claire, DrCurrent director
  • SEGHEZZI, GrazianoCurrent director
  • SUMMERS, JamesCurrent director
  • BLUNDY, Keith Stuart, Drdirector
  • BOOS, Erwindirector
  • CAMBONI, Maria Gabriella, Drdirector
  • FOY, Matthew Jamesdirector
  • FRICKEL, Fritz-Frieder Karl Georg, Drdirector
  • GODDARD, Colindirector
  • HARLAND, Deborah, Drdirector
  • HAROLD, Theodorasecretary
  • JACKSON, Stephen Philip, Profdirector
  • JONES, Elaine, Drdirector
  • KERR, Simon Christopherdirector
  • LUTHER, Davidsecretary
  • MOORE, Michael, Drdirector
  • MUNCEY, Andrewsecretary
  • NUECHTERLEIN, Caroledirector
  • PATRICK, Denisdirector
  • SAXTON, Tracydirector
  • WALDRON, Andrew Jonathandirector
  • WOODMAN, Robbie, Drdirector

Funding rows

Sources